Also available from:

On Sale: Sep 17, 2001
Page Count: 448 pages
Publisher: Da Capo
ISBN-13: 9780738205441

Millions of children take Ritalin for Attention-Deficit Hyperactivity Disorder. The drug’s manufacturer, Novartis, claims that Ritalin is the “solution” to this widespread problem. But hidden behind the well-oiled public-relations machine is a potentially devastating reality: children are being given a drug that can cause the same bad effects as amphetamine and cocaine, including behavioral disorders, growth suppression, neurological tics, agitation, addiction, and psychosis. Talking Back to Ritalin uncovers these and other startling facts and translates the research findings for parents and doctors alike. An advocate for education not medication, Dr. Breggin empowers parents to channel distracted, disenchanted, and energetic children into powerful, confident, and brilliant members of the family and society.

Genre:

$24.99

$31.99 CAD

Format

Trade Paperback

Format:

Trade Paperback $24.99 $31.99 CAD

By clicking ‘Sign Up,’ I acknowledge that I have read and agree to Hachette Book Group’s Privacy Policy and Terms of Use

Peter Breggin

About the Author

Peter R. Breggin, M.D., is the author of a dozen books, including Talking Back to Prozac and The Antidepressant Factbook. He lives in Ithaca, New York.

Learn more about this author

Contributors

Also available from:

Details

Description

Genre:

Formats and Prices

Price

Price

Format

Format:

You May Also Like

Newsletter Signup

Peter Breggin

About the Author